ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1444

Characterization and Comparison of MRI Findings in Axial Spondyloarthritis, Axial Psoriatic and Chronic Non-inflammatory Back Pain

Mauricio Parada1, maría Luisa Molina1, Daniel Ríos1, Daniela Suarez1, Natalie Hitchin2, Cristóbal Bravo2, Nicolás Guzmán2 and Annelise Goecke1, 1Hospital Clínico Universidad de Chile, santiago, Chile, 2Universidad de Chile, Santiago, Chile

Meeting: ACR Convergence 2024

Keywords: Imaging, Psoriatic arthritis, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: MRI of the sacroiliac joints (SIJ) is part of the evaluation of patients with suspected axial spondyloarthritis (axSpA). However, sacroiliitis (SI) could be a nonspecific finding, potentially resulting from mechanical stress or degeneration. 


Furthermore, in the subgroup of patients with psoriatic arthritis with axial involvement (axPsA), the findings on MRI are still not completely clarified and do not have sufficient data comparing them with MRI findings in patients with chronic non-inflammatory back pain (NI-CBP).


Our objective was to calculate the sensitivity, specificity, positive and negative predictive values (PPV, NPV) and likelihood ratio (LR) of a positive MRI for SI according to the ASAS/OMERACT criteria for axPsA and non-psoriatic spondyloarthritis (nPsA-axSpA). We identified clinical variables that were independently associated with SI and described inflammatory spinal lesions (ISL) for each subgroup.

Methods: Total spine and SIJ MRIs performed at the University of Chile’s Clinical Hospital from adults with nPsA-axSpA, axPsA and  NI-CBP followed by the rheumatology service were retrospectively analyzed. The gold standard was diagnosis by a rheumatologist. 

For patients with nPsA-axSpA and NI-CBP, we analyzed the MRIs performed during 2015, whereas for axPsA those performed between 2015 and 2021.

MRIs were performed with a 1.5 T resonator without contrast medium. Images were analyzed by two expert radiologists blinded to the clinical data. ISL were defined according to ASAS/OMERACT definitions.


ANOVA test was used to analyze continuous data and Chi² for categorical data. Sensitivity, specificity, PPV, NPV and LR were calculated with the R program and multivariate analysis with SPSS software. 

Results: A total of 95 patients were analyzed, 29 nPsA-axSpA, 21 axPsA and 45 NI-CBP. The sensitivity of MRI SI was 83% for nPsA-axSpA, 77% for axPsA and the specificity was 91% for both subgroups. For the entire axSpA group (axPsA + nPsA-axSpA), the PPV was 91% and NPV was 80%.  The LR (+) was 8.8 and the LR (-) was  0.21.


Advanced age (OR: 1.06; CI: 1.01-1.11), BMI (OR: 1.24; CI 1.04-1.47), physical activity (OR: 3.85; CI 1.09 – 13.66), inflammatory back pain (OR: 35.11; CI 2.01 -614.36) and extra-articular manifestations (OR : 1.72, 1.02-2.9), were independently associated with SI in multivariate analysis.


In the entire sample 38 patients (40%) presented some ISL, 8 (18%) in NI-CBP, 14 (48%) in nPsA-axSpA and 16 (76%) in axPsA. The concomitant finding of spondylitis, costovertebral  and facet arthritis occurred only in axSpA group, 6 patients (28.5%) with AxPsA, 1 (3.4%) patient with nPsa-axSpa.

Conclusion: The sensitivity and specificity of SI on MRI  in our cohort was 83% for nPsA-axSpA and  77% for axPsA. Advanced age, BMI and  physical activity were associated with SI. ISL may occur in patients with NI-CBP, although the concomitance of 3 ISL was only observed in axPsA and more frequently in axPsA.


Disclosures: M. Parada: None; m. Molina: Novartis, 6; D. Ríos: None; D. Suarez: None; N. Hitchin: None; C. Bravo: None; N. Guzmán: None; A. Goecke: Abbvie, 6.

To cite this abstract in AMA style:

Parada M, Molina m, Ríos D, Suarez D, Hitchin N, Bravo C, Guzmán N, Goecke A. Characterization and Comparison of MRI Findings in Axial Spondyloarthritis, Axial Psoriatic and Chronic Non-inflammatory Back Pain [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/characterization-and-comparison-of-mri-findings-in-axial-spondyloarthritis-axial-psoriatic-and-chronic-non-inflammatory-back-pain/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-and-comparison-of-mri-findings-in-axial-spondyloarthritis-axial-psoriatic-and-chronic-non-inflammatory-back-pain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology